Suggestions
Journal Information
Vol. 93. Issue 1. (In progress)
(January - February 2027)
Cite
Cite
Share
Download PDF
More article options
Visits
196
Vol. 93. Issue 1. (In progress)
(January - February 2027)
Original article
Full text access

Development and validation of an evidence-based otorhinolaryngological care protocol for patients with achondroplasia: a pilot study

Visits
196
Cynthia Morenoa,*
Corresponding author
cyncasti8@gmail.com

Corresponding author.
, Marcial Galerab,c
a Universidade Federal de Mato Grosso (UFMT), Hospital Universitário Júlio Müller (HUJM), Head and Neck Unit, Cuiabá, MT, Brazil
b Universidade Federal de São Paulo (UNIFESP), São Paulo, SP, Brazil
c Universidade Federal de Mato Grosso (UFMT), Pediatrics Department, Cuiabá, MT, Brazil
Highlights

  • •

    Evidence-based ENT protocol for achondroplasia.

  • •

    Evidence-based otorhinolaryngological manifestations in patients with achondroplasia.

  • •

    Content validation by expert panel (pediatrician, geneticist, and otolaryngologist).

  • •

    The protocol was applied in a clinical setting, confirming its clinical feasibility.

  • •

    Structured care improves assessment, diagnosis, treatment and future research.

This item has received
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Figures (3)
fig0005
fig0010
fig0015
Tables (3)
Table 1. Synthesis of prevalences of otorhinolaryngological manifestations in the 11 prevalence studies included in the review.
Tables
Table 2. Evaluation of protocol items by the expert panel according to the Likert scale and the Content Validity Index (CVI).
Tables
Table 3. Otorhinolaryngological care protocol for patients with achondroplasia.
Tables
Abstract
Objective

To develop an evidence-based otorhinolaryngological care protocol for patients with achondroplasia, and to evaluate its content validity and clinical applicability through expert assessment and pilot testing.

Methods

This methodological study was conducted in three stages. Initially, this evidence-based protocol was developed based on a literature review of the most prevalent otorhinolaryngological manifestations in patients with achondroplasia, utilizing the PRISMA guidelines. guidelines for systematic reviews. Second, content validation was performed by a panel of three specialists (a pediatrician, a geneticist, and an otorhinolaryngologist) and conducted in two consecutive rounds using a structured questionnaire on the Google Forms platform. The questionnaire employed the Likert scale and the CVI (Content Validity Index). Third, a pilot application of the protocol was conducted in four patients aged 2–10 years, with confirmed diagnosis of achondroplasia, followed at a tertiary outpatient clinic, to assess feasibility, clarity, and applicability in clinical practice.

Results

The protocol provides systematic and comprehensive data collection, including clinical history, otorhinolaryngological examination, and complementary assessments. Content validation demonstrated high agreement among experts, with a CVI of 0.91, indicating excellent clarity, relevance and applicability. At pilot phase, the protocol proved to be feasible and easy to apply, with an average application time of 34-minutes.

Conclusion

The proposed protocol is an evidence-based, feasible, and clinically applicable tool that supports standardized otorhinolaryngological assessment in patients with achondroplasia. Its implementation may contribute to early identification of complications, guiding appropriate therapeutic decision-making, improving the quality of care and providing a rich database for future research.

Level of Evidence 4/5

This methodological study involved the development of an evidence-based clinical protocol, expert content validation, and pilot application in a clinical setting, without a comparative or interventional design.

Keywords:
Achondroplasia
Otorhinolaryngological manifestations
Integrative review
Care protocol
Abbreviations:
ACH
ENT
MEDLINE
BVS
LILACS
MeSH
PRISMA
PSQ
CVI
OSA
Full Text
Introduction

Achondroplasia (ACH) is the most common disproportionate short stature skeletal dysplasia; its estimated worldwide prevalence at birth is 4.6 per 100,000,1 with incidence at birth of 1:10,000 to 1:30,000.2 In Latin American countries, the prevalence ranges from 0.26 to 0.45 per 10.000 births.1

The main physical characteristics include short stature; rhizomelia; macrocephaly; midface hypoplasia; small chest; thoracolumbar kyphosis; lumbar hyperlordosis; limited elbow extension; short fingers and trident-shaped hands; hypermobile hips and knees; medial bowing of the legs and hypotonia.3

Craniofacial abnormalities in achondroplasia, including premature fusion of the skull base synchondroses, maxillary hypoplasia, cranial foramina stenosis and cervicomedullary compression, compromise both the spatial relationships and tone of the upper airway, as well as auditory functioning. Associated with factors such as macroglossia, pharyngeal hypotonia, high arched palate and depressed nasal bridge, further contribute to the otorhinolaryngological manifestations of the disease.4–12

A systematic review with meta-analysis on the impact of achondroplasia in Latin American patients, which studied outcomes such as mortality, physical comorbidities, humanistic and economic outcomes, reports that ENT disorders accounted for 21.42% of the physical comorbidities. Furthermore, in a pooled analysis of 230 patients, 5 (2.17%) underwent adenotonsillectomy, 75 (32.6%) had mildly to moderately increased apnea index, 75 (32.6%) had desaturations during sleep and apnea, and 32% pooled proportion of ENT disorders (hearing loss, recurrent otitis media, need for surgical treatment, speech development delay, hypotonia, adenoid hypertrophy, snoring, tonsillectomy and tympanic membrane perforation) was observed, demonstrating the importance of otorhinolaryngological symptoms in these patients.1 Another study demonstrates, in published case series, that clinically significant obstructive apnea is reported in about one-third of individuals of all ages with achondroplasia. Middle ear dysfunction is present in 50%–70% of cases, which results in approximately 50% of individuals requiring ventilation tube insertion at some point in life, and estimates of hearing loss frequency range from 38% to 60% in achondroplasias population.3

Currently, there are no specific protocols described in the literature for otorhinolaryngological management of patients with achondroplasia, and care of these patients is based on generalist practices.

Therefore, the objective of this study was to develop, validate the content, and conduct a pilot application of an otorhinolaryngological care protocol for patients with achondroplasia in a clinical setting.

The clinical protocol was developed based on evidence, followed structured stages, including the identification of care gaps, a literature systematic review, and structuring with a definition of theme, title, presentation, introduction, objective, target population, included approaches, research questions, implementation indicators, methods for evidence search, references, and documentation, as recommended in the literature.13,14

The development and implementation of a specific otorhinolaryngological care protocol for patients with achondroplasia aims to standardize follow up of disease manifestations, prevent complications from untreated dysfunctions, and increase the accuracy of therapeutic indications.

Methods

This methodological study, conducted between April 2024 and February 2026, was developed in three stages. The first comprised an integrative literature review15,16 on otorhinolaryngological manifestations in achondroplasia, guided by the research question: “What are the main otorhinolaryngological manifestations in patients with achondroplasia described in worldwide literature?” Searches were conducted in the MEDLINE, BVS (Biblioteca Virtual em Saúde), LILACS, and Cochrane Library databases, using Medical Subject Headings (MeSH/DeCs) descriptors combined with Boolean operators.

Articles published between 2010 and 2025, in Portuguese, English or Spanish, with open access to full text were included, studies selection was conducted independently by two reviewers according to inclusion and exclusion criteria according to PRISMA guidelines17 and evaluated using the Joana Briggs Institute critical appraisal tools,18–26 excluding articles with a score below 70%. Data analysis was qualitative with thematic categorization and descriptive statistical analysis, profiling the manifestations to support the protocol development. The validated Brazilian Portuguese version of the Pediatric Sleep Questionnaire (PSQ) was used in the protocol for obstructive sleep apnea screening, given its good sensitivity and specificity relative to polysomnography.27

The second stage involved content validation by a panel of experts composed of a pediatrician, a geneticist, and an otorhinolaryngologist. This was conducted in two consecutive rounds using a structured Likert-scale questionnaire, in which each item in each session received ratings from 1 to 4, corresponding to the following options: (1) Strongly disagree; (2) Partially disagree; (3) Partially agree; (4) Strongly agree. Assessments were performed using the Google Forms.28 Based on the results of the second round, the CVI (Content Validity Index) was calculated: first the CVI of each item was calculated, obtained by the ratio between the sum of the item scores assigned by the three experts and the maximum possible score, which in this case is 12, and subsequently the arithmetic mean between of all items scores was performed to determine the overall CVI of the protocol. After each round, the experts’ contributions were analyzed and incorporated into the document, resulting in its final version.

In the third stage, a pilot application of protocol was conducted in a convenience sample of patients with a confirmed diagnosis of achondroplasia, followed at the medical genetics’ outpatient clinic of the Hospital Universitário Júlio Muller, Universidade Federal de Mato Grosso (HUUFMT), aged 2–14 years, to assess feasibility, clarity, and applicability in clinical practice.

ResultsLiterature review

The literature review included 27 studies,1,2,4–7,10,29–48 comprising 15 primary and 12 secondary studies. Review articles were retained for their informative value, with no risk of duplication, as they were not used to estimate prevalence. The selection process was completed using a PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses17 flow diagram, presented in Fig. 1.

Fig. 1.

Study selection process flow diagram adapted from PRISMA Statement recommendations.17 Source: Author.

Regarding the characterization of the selected studies, geographical distribution showed a significant concentration of scientific output in Europe (39.26%), Asia (23.69%), and North America (22.22%); Latin America accounted for 10.81% of studies, with Brazil representing 5.25%. Among the 27 studies, 12 (44.44%) focused on the pediatric population, 5 (18.52%) on the adult population, and 10 (37.04%) included participants from both age groups.

An analysis of the absolute citation frequency of each otorhinolaryngological manifestation per article was performed across the 27 studies, with the findings presented in Fig. 2.

Fig. 2.

Treemap chart with absolute frequency of otorhinolaryngological manifestations citation in prevalence studies included in the review. Source: Author. Note: Absolute frequency of citation for each manifestation was used since the same study may cite more than one manifestation.

An analysis of the absolute citation frequency of each otorhinolaryngological manifestation per article was also conducted based on 11 prevalence studies5,7,29,30,32,34,36,37,40,41,44 and the results are presented in Fig. 3.

Fig. 3.

Treemap chart with absolute frequency of otorhinolaryngological manifestations citation in prevalence studies included in the review. Source: Author. Note: Absolute frequency of citation for each otorhinolaryngological manifestation was used since the same study may cite more than one manifestation.

A synthesis of the range of each otorhinolaryngological manifestation reported in the 11 prevalence studies reviewed is summarized in Table 1.

Table 1.

Synthesis of prevalences of otorhinolaryngological manifestations in the 11 prevalence studies included in the review.

Otorhinolaryngological Manifestations  Reference 
Otitis media (72.9%)  5
Hearing loss (43.8%) 
Enlarged adenoid (25.7%) 
Cholesteatomatous otitis media (2.9%) 
OSA (30.2%)  29
Snoring (94.3%) 
Otitis media (54.7%) 
Hearing loss (9.4%) 
Enlarged adenoid (56.6%) 
Speech and language delay (40.8%) 
Learning difficulties (14.7%) 
OSA (70.37%)  7
Adenotonsillar hypertrophy (62.9%) 
Hearing loss (53%)  30
Conductive (63%) 
Mixed (33%) 
Sensorioneural (4%) 
OSA (38.4%)  41 
OSA (59%)  40
Snoring (86%) 
Mild OSA (13.6%)  36
Moderate OSA (13.6%) 
Severe OSA (72.7%) 
Mixed apnea (37%) 
Adenotonsillar hypertrophy (63.7%) 
OSA (53.8%)  37
Otitis media (37%) 
Middle ear dysfunction (54%) 
Hearing loss (11%) 
Speech delay (41%) 
OSA (56%)  44
Mild (29%) 
Moderate (9%) 
Severe (16%) 
Learning difficulties (34%) 
OSA (33%)  32
Snoring (77%) 
OSA (54.3%)  34
Mild (28.26%) 
Moderate (15.21%) 
Severe (10.86%) 
Snoring (69.9%) 

The results demonstrate that respiratory manifestations, such as snoring and obstructive sleep apnea, and otological manifestations, such as otitis media and hearing loss, constitute the most prevalent otorhinolaryngological complications in achondroplasia.

Content validation

Regarding the results of the protocol evaluation by the expert panel, consensus was reached on the adequacy and applicability, with high agreement among the experts, allowing for final validation of the instrument content with an overall Content Validity Index (CVI) of 0.94. Table 2 presents the protocol evaluation items as rated by the experts, using the Likert scale and the Content Validity Index (CVI).

Table 2.

Evaluation of protocol items by the expert panel according to the Likert scale and the Content Validity Index (CVI).

Question  Pediatric evaluator  Geneticist evaluator  ENT evaluator  CVI (Content Validity Index) 
The items on this form are relevant for the initial otolaryngological evaluation of patients with achondroplasia.  4  4  4  1 
The requested information is clear and logically organized for completion in clinical practice.  4  4  4  1 
The length (number of items) of this form is adequate for routine outpatient care (neither excessive nor insufficient).  4  3  3  0.83 
I believe this form is feasible to fill out in most of the services where I work/am familiar.  4  3  4  0.91 
Questions about pregnancy are relevant for the otolaryngological follow-up of patients with achondroplasia.  4  3  4  0.83 
The items in this section allow you to properly identify relevant information about your pregnancy.  4  4  4  1 
The wording of the items is clear and easy for the professional who will be filling them out to understand.  4  4  4  1 
The amount of information requested in this section is adequate for routine use.  4  4  3  0.91 
Questions about childbirth are relevant for the otolaryngological follow-up of patients with achondroplasia.  4  3  4  0.91 
The items in this section allow for the proper identification of complications during childbirth.  4  4  4  1 
The wording of the items is clear and easy for the professional who will be filling them out to understand.  4  4  4  1 
The amount of information requested in this section is adequate for routine use.  4  4  3  0.91 
Questions about newborns are relevant for the otolaryngological follow-up of patients with achondroplasia.  4  4  4  1 
The items in this section allow you to properly identify relevant information about the newborn.  4  4  3  0.91 
The wording of the items is clear and easy for the professional who will be filling them out to understand.  4  4  4  1 
The amount of information requested in this section is adequate for routine use.  4  4  4  1 
Questions regarding the diagnosis of achondroplasia are relevant for the otolaryngological follow-up of patients with achondroplasia.  4  3  4  0.91 
The items in this section allow you to properly identify relevant information about the newborn.  4  4  3  0.91 
The wording of the items is clear and easy for the professional who will be filling them out to understand.  4  4  4  1 
The amount of information requested in this section is adequate for routine use.  4  3  3  0.83 
Questions about growth milestones are relevant for the otolaryngological follow-up of patients with achondroplasia.  4  3  4  0.91 
The items in this section allow for the proper identification of relevant feeding difficulties (swallowing, food transition).  4  3  4  0.91 
The wording of the items is clear and easy for the professional who will be filling them out to understand.  4  4  4  1 
The amount of information requested in this section is adequate for routine use.  4  4  4  1 
Questions about motor development are relevant for the otolaryngological follow-up of patients with achondroplasia.  4  4  4  1 
The items in this section allow for the proper identification of relevant feeding difficulties (swallowing, food transition).  4  3  4  0.91 
The wording of the items is clear and easy for the professional who will be filling them out to understand.  4  4  4  1 
The amount of information requested in this section is adequate for routine use.  4  3  4  0.91 
Questions about breastfeeding and the introduction of solid foods are relevant for the otolaryngological follow-up of patients with achondroplasia.  4  4  4  1 
The items in this section allow for the proper identification of relevant feeding difficulties (swallowing, food transition).  4  3  4  0.91 
The wording of the items is clear and easy for the professional who will be filling them out to understand.  4  3  3  0.83 
The amount of information requested in this section is adequate for routine use.  4  3  4  0.91 
The items in this section are suitable for tracking speech, language, and learning changes in patients with achondroplasia.  4  4  4  1 
The questions allow for the early identification of signs of delays or communication disorders.  4  4  4  1 
Information regarding language, speech, schooling/daycare, and learning difficulties is relevant to the context of the protocol.  4  3  4  0.91 
The language used in this section is clear and understandable for professionals in the field.  4  4  3  0.91 
The items in this section comprehensively and pertinently cover the main otorhinolaryngological signs and symptoms relevant to achondroplasia.  4  3  4  0.91 
The structure of the questions facilitates the identification of the main otorhinolaryngological signs and symptoms.  4  3  4  0.91 
Questions about otorhinolaryngological signs and symptoms are appropriate.  4  3  4  0.91 
This section is feasible to implement in practice (number of items, clarity, completion time).  4  4  3  0.91 
The items in this section adequately address the main relevant anatomical and functional changes in patients with achondroplasia.  4  4  4  1 
The registration method (YES/NO/NOTES and specific fields) is clear and functional.  4  3  4  0.91 
This section promotes a systematic and comprehensive assessment of the otolaryngological examination.  4  3  4  0.91 
The number of items is appropriate for the needs of an outpatient clinic, without making the examination excessively time-consuming.  4  2  4  0.83 
The inclusion of complete audiometry, videonasopharyngolaryngoscopy, and polysomnography is relevant for the follow-up of patients with achondroplasia.  4  4  4  1 
The available fields are sufficient to record the most relevant findings from the examinations.  4  3  4  0.91 
The recording method (normal/altered + observations) is simple and suitable for clinical practice.  4  3  4  0.91 
This section promotes the integration of complementary tests into the clinical reasoning of the protocol.  4  4  4  1 
The use of PSQ is appropriate and well-founded for screening sleep-related breathing disorders in children with achondroplasia (27).  4  4  4  1 
The way PSQ is integrated into the protocol makes it easier for professionals to apply and interpret (27).  4  4  4  1 
The guidelines regarding the cutoff point (a result greater than 9 “YES” responses) are clear.  4  4  4  1 
I believe it is feasible to apply the PSQ (Product Quality Assessment) to the daily service routines in the areas where I work/am familiar (27).  4  3  4  0.91 
The annual follow-up form is suitable for monitoring the otorhinolaryngological clinical evolution of patients with achondroplasia over time.  4  3  4  0.91 
The structure of this form maintains consistency with the initial assessment, facilitating comparison between consultations.  4  4  4  1 
The number of items and the method of recording are feasible for annual use in service practice.  4  4  3  0.91 
This form facilitates the organization of longitudinal follow-up and the identification of relevant clinical changes.  4  3  4  0.91 
Is the protocol applicable to real-world clinical practice?  4  4  4  1 
Does the protocol contribute to improving care for patients with achondroplasia?  4  4  4  1 
Is the protocol ready for clinical use?  4  3  4  0.91 
0.94

After content validation, the final version of the protocol includes two assessment forms, one for the first consultation and another for otorhinolaryngologic follow-up visits.

The first form includes information on pregnancy, delivery, newborn, achondroplasia diagnosis, growth milestones, motor development milestones, feeding, speech and language development, otorhinolaryngological signs and symptoms, otorhinolaryngological physical examination, and complementary ENT tests, as well as the Pediatric Sleep Questionnaire (PSQ) Brazilian Portuguese version for obstructive sleep apnea (OSA) screening, with good sensitivity and specificity compared to polysomnography.27 If the PSQ score is ≥9, this is suggestive of OSA, and specific management will be discussed case by case. The second form includes information on intercurrent events and evolution since the previous consultation, ongoing treatments, growth milestones, motor development milestones, feeding, speech and language development, otorhinolaryngological signs and symptoms, otorhinolaryngological physical examination, complementary ENT tests, and the Pediatric Sleep Questionnaire (PSQ).27 The final protocol structure is presented in Table 3.

Table 3.

Otorhinolaryngological care protocol for patients with achondroplasia.

Initial outpatient care form (first consultation with ent)
Patient's name:
Medical Record Number: Date of Birth: / /
Age: Sex: () F () M
Name of the person in charge:
Telephone:
Medical History Reports: ____________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
PREGNANCY INFORMATION
YESNOObservations
Prenatal care
Alcoholism
Smoking
Other drugs
Infection
Familiar history of congenital anomaly
Changes in gestational ultrasound
Prenatal diagnosis of achondroplasiaIf so, when?
Fetal distress
INFORMATION ABOUT CHILDBIRTH
Type of deliveryVaginal () Cesarean ()
Gestational age
Maternal age
NEWBORN INFORMATION
Weight
Length
Head circumference
Apgar
YESNOObservations
Perinatal complicationsIf so, which ones?
Phenotypic alterationsIf so, which ones?
Congenital infectionObservations
ACHONDROPLASIA DIAGNOSIS
Age
Diagnostic method(s)Clinical () Radiological () Genomic ()
YESNOObservations
Currently undergoing specific treatmentMedication and onset
Other treatments
GROWTH MILESTONES Hoover-Fong et al.49
MeasurementPercentileObservations
Weight
Head circumference
Height
Weight/Height
MOTOR DEVELOPMENT Ireland et al.50
AgePercentileObservations
Cervical control (months)
Sat with support (months)
Sat up without support (months)
Crawled (months)
Independent march (months)
FEEDING
BREASTFEEDINGExclusive breastfeeding () until ___ months. Formula () Mixed () up to ___ months.
Notes:
Feeding introductionwithout difficulty ()with difficulty ()
Observations (need for support, semi-sitting, hypotonia, acceptance of solid foods/tongue protrusion reflex, food refusal, cough, choking).
SPEECH AND LANGUAGE DEVELOPMENT Ireland et al.50
AgePercentileObservations
Social smile
Babbling
First words
First sentences
Understands verbal commands.
Observations (characteristics, form of communication):
YESNOObservations
Speech therapyObservations
Is he/she in school or daycare?Stage?
Learning difficultiesObservations
OTORHINOLARYNGOLOGICAL SIGNS AND SYMPTOMS
YESNOObservations
Nasal obstruction
Respiratory noise
Mouth breathing
Snoring
Tonsillitis
OtitisOtorrhea?
Rhinosinusitis
Hearing loss
Salivar control
Clinical suspicion of Obstructive Sleep Apnea (OSA)
Dysphagia() Liquid () Paste () Solid
Choking() Liquid () Paste () Solid
Previous aspiration pneumonia
Otorhinolaryngological SurgeryWhich?
OTORHINOLARYNGOLOGICAL EXAMINATION
YESNOObservations
Oropharyngeal abnormalities
Palate abnormalities
Dental abnormalities
Language abnormalities
Anterior rhinoscopy
Otoscopy
Facial skeletal abnormalities (Midface hypoplasia, micrognathia, retrognathia)
Skull base / possible narrowing of the foramen magnum (clinical suspicion)
Other facial morphological abnormalities
ADDITIONAL TESTS IN OTOLARYNGOLOGY
ExamNormalChangedUnrealized
Pure-tone audiometry
Impedance audiometry
Auditory Evoked Potentials
Videonasopharyngolaryngoscopy
Polysomnography
PSQ QUESTIONNAIRE PORTUGUESE VERSION – BRAZIL Martins et al.27 APPLICATION DATE:
While your child sleeps:YesNoDon't know 
A1. Snores more than half the time 
A2. Always snores 
A3. Snores loudly 
A4. Has deep or noisy breathing. 
A5. Are you having difficulty breathing or struggling to breathe? 
A6. Have you ever seen your son (or daughter) stop breathing during sleep? 
Your son (or daughter):
A7. Tends to breathe with their mouth open during the day. 
A8. Wakes up with a dry mouth. 
A9. Wets the bed occasionally. 
Your son (or daughter):
B1. Do you wake up tired in the morning? 
B2. Do you have trouble sleeping during the day? 
B3. Has a teacher or other person ever commented that your child seems sleepy during the day? 
B4. Is it difficult to wake your child in the morning? 
B5. Does your child wake up with a headache in the morning? 
B6. Did your child stop growing normally at any point since birth? 
B7. Is your child overweight? 
Your son often:
C1. He doesn't seem to hear when spoken to directly. 
C2. Has difficulty organizing tasks and activities. 
C3. Is easily distracted by external stimuli. 
C4. Fidgets with hands or feet or becomes restless when seated. 
C5. Cannot sit still or often acts as if plugged into an electrical outlet. 
C6. Interrupts people or butts into conversations or games. 
TOTAL 
Action to take after a positive PSQ (> 9 "Yes" responses): () Request polysomnography () Refer to a sleep specialist. () Clinical follow-up Notes:_____________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
FOLLOW-UP ENT RECORD
Patient's name:
Medical Record Number: Date of Birth: / /
Age: Sex: () F () M
Name of the person in charge:
Telephone:
Time interval since last ENT evaluation
Intervening events in the last year: () Hospitalizations () Surgeries () Recurrent infections
Medical History Reports:______________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
TREATMENTS
  YESNOObservations
Currently undergoing specific treatment 
Other treatments 
GROWTH MILESTONES Hoover-Fong et al.49
  MeasurementPercentileObservations
Weight 
Head circumference 
Height 
Weight/Height 
MOTOR DEVELOPMENT Ireland et al.50
  AgePercentileObservations
Cervical control (months) 
Sat with support (months) 
Sat up without support (months) 
Crawled (months) 
Independent march (months) 
FEEDING
without difficulty () with difficulty () Which ones:
Observations (need for support, semi-sitting, hypotonia, acceptance of solid foods/tongue protrusion reflex, food refusal, cough, choking).
SPEECH AND LANGUAGE DEVELOPMENT Ireland et al.50
(Characteristics, form of communication and specific evaluations):
  YESNOObservations
Is he/she in school or daycare?  Stage?
Learning difficulties 
Speech therapy 
OTORHINOLARYNGOLOGICAL SIGNS AND SYMPTOMS
  YESNOObservations
Nasal obstruction 
Respiratory noise 
Mouth breathing 
Snoring 
Tonsillitis 
Otitis  Otorrhea?
Rhinosinusitis 
Hearing loss 
Salivary control 
Clinical suspicion of Obstructive Sleep Apnea (OSA) 
Dysphagia  () Liquid () Paste () Solid
Choking  () Liquid () Paste () Solid
Previous aspiration pneumonia 
Otorhinolaryngological Surgery  Which?
OTORHINOLARYNGOLOGICAL EXAMINATION
  YESNOObservations
Oropharyngeal abnormalities 
Palate abnormalities 
Dental abnormalities 
Language abnormalities 
Anterior rhinoscopy 
Otoscopy 
Facial skeletal abnormalities (Midface hypoplasia, micrognathia, retrognathia) 
Skull base / possible narrowing of the foramen magnum (clinical suspicion) 
Other facial morphological abnormalities 
ADDITIONAL TESTS IN OTORHINOLARYNGOLOGY
Exam  NormalChangedUnrealized
Pure-tone audiometry 
Impedance audiometry 
Auditory Evoked Potentials 
Videonasopharyngolaryngoscopy 
Polysomnography 
PSQ QUESTIONNAIRE PORTUGUESE VERSION – BRAZIL Martins et al.27 APPLICATION DATE:
While your child sleeps:YesNoDon't know
A1. Snores more than half the time
A2. Always snores
A3. Snores loudly
A4. Has deep or noisy breathing.
A5. Are you having difficulty breathing or struggling to breathe?
A6. Have you ever seen your son (or daughter) stop breathing during sleep?
Your son (or daughter):
A7. Tends to breathe with their mouth open during the day.
A8. Wakes up with a dry mouth.
A9. Wets the bed occasionally.
Your son (or daughter):
B1. Do you wake up tired in the morning?
B2. Do you have trouble sleeping during the day?
B3. Has a teacher or other person ever commented that your child seems sleepy during the day?
B4. Is it difficult to wake your child in the morning?
B5. Does your child wake up with a headache in the morning?
B6. Did your child stop growing normally at any point since birth?
B7. Is your child overweight?
Your son often:
C1. He doesn't seem to hear when spoken to directly.
C2. Has difficulty organizing tasks and activities.
C3. Is easily distracted by external stimuli.
C4. Fidgets with hands or feet or becomes restless when seated.
C5. Cannot sit still or often acts as if plugged into an electrical outlet.
C6. Interrupts people or butts into conversations or games.
TOTAL
Action to take after a positive PSQ (> 9 "Yes" responses): () Request polysomnography () Refer to a sleep specialist. () Clinical follow-up Notes:_________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
Protocol pilot application

During the pilot phase, the protocol was applied to four male patients, with confirmed achondroplasia diagnosis, followed at the medical genetics outpatient clinic of the Hospital Universitário Júlio Muller, Universidade Federal de Mato Grosso (HUUFMT), aged 2- to 10-years, to assess feasibility, clarity, and applicability in clinical practice.

After the pilot application, no further modifications were required, and the protocol enabled the standardization of otorhinolaryngological care for patients with achondroplasia, encompassing the main otorhinolaryngological manifestations. It will facilitate clearer communication among healthcare professionals involved in their care and enable future research based on this standardization.

Discussion

At revision, the predominance of studies in the pediatric population raises concerns about the transition of care throughout life for individuals with achondroplasia.

The absolute citation frequency for each otorhinolaryngological manifestation in achondroplasia in the 27 studies is similar to that observed in other studies not included in the review.51–54

The results of the absolute citation frequency of each otorhinolaryngological manifestation per article, synthesized from 11 prevalence studies, confirmed the high prevalence of these manifestations in achondroplasia, with a predominance of respiratory and otological abnormalities.

The range of each otorhinolaryngological manifestation reported across the 11 prevalence studies was consistent with analyses of the full set of 27 studies, with sleep apnea and hearing loss ranking first in both analyses.

The findings are consistent with literature, reporting snoring prevalence from 25% to 95%51 and Obstructive Sleep Apnea (OSA) prevalence of approximately 56% in infants and 60% in adults;51 69.3% across all age groups;52 and 40.7%.53 These values are markedly higher than those in the general adult population (16%)55 and the pediatric population (1%–5%).56

The literature reports that the prevalence of otitis media in achondroplasia ranges from 48% to 80% in children up to 5-years of age, 33% in adolescents, and 17% in adults,51 much higher than in the general population by 10%–11%.57 Hearing loss occurs in 55% of achondroplastic individuals regardless of age,51 with other cohorts reporting prevalences above 70%52 and 61.1%.53 These data highlight the need for systematic otorhinolaryngological follow-up in this population.

After expert panel validation, the result was 0.94, which indicates excellent agreement on relevance, clarity, and adequacy. The protocol pilot application proved to be feasible and easy to use in an outpatient setting, with a mean application time of 34 min. However, there is still a need to expand its use through application in other healthcare settings in order to test its feasibility in different contexts and to incorporate further improvements, increasing its robustness, and thereby enable early identification of otorhinolaryngological complications, guide appropriate therapeutic decision-making, improve the quality of care, and serve as a database for future research.

Conclusions

The protocol developed in this study addressed fundamental aspects of clinical assessment, including gestational and neonatal history, developmental milestones, feeding, speech and language development, otorhinolaryngological signs and symptoms, specialized physical examination, and complementary tests, and incorporation of the Pediatric Sleep Questionnaire (PSQ) as a screening tool for sleep-disordered breathing.27

Content validation by an expert panel demonstrated high agreement regarding clarity, relevance, and applicability of the proposed items, improving the instrument. Additionally, the pilot application in patients followed at the Hospital Universitário Júlio Muller, Universidade Federal de Mato Grosso (HUUFMT) enabled its feasibility in clinical practice.

The proposed protocol is an evidence-based, feasible, and clinically applicable tool, that assists in standardized otorhinolaryngological assessment of patients with achondroplasia. Its implementation may contribute to the early complications identification, guide appropriate therapeutic decision, improve care quality, and provide a robust database for future research.

ORCID ID

Cynthia Moreno: 0009-0004-3982-9390

Marcial Galera: 0000-0002-1624-7572

Funding

This research has not received specific funding from public, commercial, or non-profit funding agencies.

Data availability statement

The authors declare that all data are available in repository.

Declaration of competing interest

The authors declare no conflicts of interest.

Acknowledgments

Phd. Wilma Anselmo Lima. Division of Otorhinolaryngology, Department of Ophthalmology, Otorhinolaryngology, Head and Neck Surgery, Ribeirao Preto Medical School ‒ University of São Paulo, Brazil.

Phd. Juan Clinton Llerena Junior. Senior researcher at the Oswaldo Cruz Foundation and collaborating professor at the Faculty of Medicine of Petrópolis. Rio de Janeiro, Brazil.

Phd. Sandra Moreira Monteiro. Pediatrics Department, Universidade Federal de Mato Grosso (UFMT), Cuiabá, MT, Brazil.

For their participation in the evaluation and content validation of the protocol, providing valuable contributions.

And to Júlio Müller University Hospital and to everyone who is part of its academic and healthcare community ‒ fellow preceptors, faculty, residents, and undergraduate students.

References
[1]
V. Fano, C.A. Kim, P. Rosselli, et al.
Impact of achondroplasia on Latin American patients: a systematic review and meta-analysis of observational studies.
Orphanet J Rare Dis., 17 (2022), pp. 4
[2]
J. Hoover-Fong, C.I. Scott, M.C. Jones.
Health supervision for people with achondroplasia.
Pediatrics., 145 (2020),
[3]
R.M. Pauli.
Achondroplasia: a comprehensive clinical review.
Orphanet J Rare Dis., 14 (2019), pp. 1
[4]
S. Fredwall, M. AlSayed, T. Ben-Omran, et al.
European achondroplasia forum practical considerations for following adults with achondroplasia.
Adv Ther., 41 (2024), pp. 2545-2558
[5]
D. Kim, J. Yoon, M.W. Suh, J.H. Lee, M.K. Park.
Otologic manifestations in patients with achondroplasia: a multicenter study.
J Int Adv Otol., 20 (2024), pp. 517-522
[6]
P.S. Kochar, P. Soin, A. Megahed.
High-resolution computed tomography temporal bone imaging in achondroplasia.
Proc (Baylor Univ Med Cent)., 34 (2021), pp. 419-421
[7]
R. Calandrelli, F. Pilato, G. D’Apolito, et al.
Airways and craniofacial assessment in children affected by achondroplasia with and without sleep-disordered breathing: quantitative magnetic resonance study.
Childs Nerv Syst., 38 (2022), pp. 1147-1154
[8]
A. Morice, M. Taverne, S. Eché, et al.
Craniofacial growth and function in achondroplasia: a multimodal 3D study on 15 patients.
Orphanet J Rare Dis., 18 (2023), pp. 88
[9]
R. Savarirayan, P. Ireland, M. Irving, et al.
International consensus statement on the diagnosis, multidisciplinary management and lifelong care of individuals with achondroplasia.
Nat Rev Endocrinol., 18 (2022), pp. 173-189
[10]
E. Sforza, G. Margiotta, V. Giorgio, et al.
What to expect of feeding abilities and nutritional aspects in achondroplasia patients: a narrative review.
Genes (Basel)., 14 (2023), pp. 199
[11]
I. Dorney, T. Otteson, D.C. Kaelber.
Epidemiology of Eustachian tube dysfunction and related otologic diagnoses among children with achondroplasia.
Int J Pediatr Otorhinolaryngol., 163 (2022),
[12]
D.E. Tunkel, E. Gough, M.B. Bober, et al.
Otolaryngology utilization in patients with achondroplasia: results from the CLARITY study.
Laryngoscope., 132 (2022), pp. 1548-1554
[13]
Brasil.
Ministério da Saúde. Protocolo clínico e diretrizes terapêuticas para acondroplasia.
Ministério da Saúde, (2019),
[14]
A. Qaseem, F. Forland, F. Macbeth, et al.
Guidelines international network: toward international standards for clinical practice guidelines.
Ann Intern Med., 156 (2012), pp. 525-531
[15]
K.D.S. Mendes, R.C.C.P. Silveira, C.M. Galvão.
Revisão integrativa: método de pesquisa para a incorporação de evidências na saúde e na enfermagem.
Texto Contexto Enferm., 17 (2008), pp. 758-764
[16]
R. Whittemore, K. Knafl.
The integrative review: updated methodology.
J Adv Nurs., 52 (2005), pp. 546-553
[17]
M.J. Page, J.E. McKenzie, P.M. Bossuyt, et al.
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.
BMJ, 372 (2021), pp. n71
[18]
E. Aromataris, R. Fernandez, C.M. Godfrey, et al.
Summarizing systematic reviews: methodological development, conduct, and reporting of an umbrella review approach.
Int J Evid Based Healthc., 13 (2015), pp. 132-140
[19]
E. Aromataris, C. Lockwood, K. Porritt, B. Pilla, Z. Jordan.
JBI manual for evidence synthesis.
[20]
A. McArthur, A. Cooper, D. Edwards, et al.
Textual evidence systematic reviews series paper 3: critical appraisal of evidence from narrative, opinion, and policy.
JBI Evid Synth., 23 (2025), pp. 833-839
[21]
S. Moola, E. Aromataris, Z. Munn.
Chapter 7: systematic reviews of etiology and risk.
JBI Manual for Evidence Synthesis,
[22]
Z. Munn, et al.
Chapter 5: systematic reviews of prevalence and incidence.
JBI Manual for Evidence Synthesis, http://dx.doi.org/10.46658/JBIMES-20-06
[23]
Z. Munn, T.H. Barker, S. Moola, et al.
Methodological quality of case series studies: an introduction to the JBI critical appraisal tool.
JBI Evid Synth., 18 (2020), pp. 2127-2133
[24]
M.D.J. Peters, C. Marnie, H. Colquhoun, et al.
Scoping reviews: reinforcing and advancing the methodology and application.
[25]
M.D.J. Peters, C. Godfrey, P. McInerney, Z. Munn, A.C. Tricco, H. Khalil.
Scoping reviews.
JBI Manual Evid Synth., 24 (2024), pp. 1-12
[26]
A.C. Tricco, E. Lillie, W. Zarin, et al.
Prisma extension for scoping reviews (PRISMA-ScR): checklist and explanation.
Ann Intern Med., 169 (2018), pp. 467-473
[27]
C.A.N. Martins, M.M. Deus, I.C. Abile, et al.
Translation and cross-cultural adaptation of the pediatric sleep questionnaire (PSQ) into Brazilian Portuguese.
Braz J Otorhinolaryngol., 88 (2022), pp. S63-S69
[28]
Google LLC.
Google forms.
Google LLC, (2024),
[29]
M. Soğukpınar, G.Ü Demir, G.E. Utine, et al.
Review of patients with achondroplasia: a single-center’s experience with follow-up and associated morbidities.
Eur J Pediatr., 183 (2024), pp. 3819-3829
[30]
S.O. Fredwall, B. Åberg, H. Berdal, R. Savarirayan, J. Solheim.
Hearing loss in Norwegian adults with achondroplasia.
Orphanet J Rare Dis., 16 (2021), pp. 468
[31]
L.M. DelRosso, E. Gonzalez-Toledo, R. Hoque.
A three-month-old achondroplastic baby with both obstructive apneas and central apneas.
J Clin Sleep Med., 9 (2013), pp. 287-289
[32]
S. Julliand, M. Boulé, G. Baujat, et al.
Lung function, diagnosis, and treatment of sleep-disordered breathing in children with achondroplasia.
Am J Med Genet A., 158A (2012), pp. 1987-1993
[33]
J. Llerena Jr, C.A. Kim, V. Fano, et al.
Achondroplasia in Latin America: practical recommendations for the multidisciplinary care of pediatric patients.
BMC Pediatr., 22 (2022), pp. 492
[34]
S. Afsharpaiman, D.O. Sillence, M. Sheikhvatan, J.E. Ault, K. Waters.
Respiratory events and obstructive sleep apnea in children with achondroplasia: investigation and treatment outcomes.
Sleep Breath., 15 (2011), pp. 755-761
[35]
S. Afsharpaiman, A. Saburi, K.A. Waters.
Respiratory difficulties and breathing disorders in achondroplasia.
Paediatr Respir Rev., 14 (2013), pp. 250-255
[36]
K.L. Booth, D.A. Levy, D.R. White, J.D. Meier, P.P. Pecha.
Management of obstructive sleep apnea in children with achondroplasia: outcomes of surgical interventions.
Int J Pediatr Otorhinolaryngol., 138 (2020),
[37]
J.R.M. Ceroni, D.C.Q. Soares, L.C. Testai, et al.
Natural history of 39 patients with achondroplasia.
Clinics (Sao Paulo)., 73 (2018),
[38]
B. Fauroux, M. AlSayed, T. Ben-Omran, et al.
Management of sleep-disordered breathing in achondroplasia: guiding principles of the European Achondroplasia Forum.
J Rare Dis., 20 (2025), pp. 233
[39]
S.O. Fredwall, G. Maanum, H. Johansen, H. Snekkevik, R. Savarirayan, I.B. Lidal.
Current knowledge of medical complications in adults with achondroplasia: a scoping review.
Clin Genet., 97 (2020), pp. 179-197
[40]
S.O. Fredwall, B. Øverland, H. Berdal, et al.
Obstructive sleep apnea in Norwegian adults with achondroplasia: a population-based study.
Orphanet J Rare Dis., 16 (2021), pp. 156
[41]
J.E. Hoover-Fong, A.Y. Alade, S.S. Hashmi, et al.
Achondroplasia natural history study (CLARITY): a multicenter retrospective cohort study of achondroplasia in the United States.
Genet Med., 23 (2021), pp. 1498-1505
[42]
T. Kubota, M. Adachi, T. Kitaoka, et al.
Clinical practice guidelines for achondroplasia.
Clin Pediatr Endocrinol., 29 (2020), pp. 25-42
[43]
J.M. Legare, P. Modaff.
Achondroplasia.
[44]
R. Tenconi, S. Khirani, A. Amaddeo, et al.
Sleep-disordered breathing and its management in children with achondroplasia.
Am J Med Genet A., 173 (2017), pp. 868-878
[45]
M.J. Wright, M.D. Irving.
Clinical management of achondroplasia.
Arch Dis Child., 97 (2012), pp. 129-134
[46]
E.C. Yee, A.T. Remulla.
A case report on obstructive sleep apnea in a pediatric patient with achondroplasia.
Acta Med Philipp, 57 (2023),
[47]
M. Zaffanello, G. Cantalupo, G. Piacentini, et al.
Sleep-disordered breathing in children with achondroplasia.
World J Pediatr., 13 (2017), pp. 8-14
[48]
J. Jung, C. Yang, S. Lee, J. Choi.
Bilateral ossiculoplasty in 1 case of achondroplasia.
Korean J Audiol., 17 (2013), pp. 142-147
[49]
J.E. Hoover-Fong, K.J. Schulze, A.Y. Alade, et al.
Growth in achondroplasia including stature, weight, weight-for-height and head circumference from CLARITY: achondroplasia natural history study - a multi-center retrospective cohort study of achondroplasia in the US.
Orphanet J Rare Dis., 16 (2021), pp. 522
[50]
P.J. Ireland, S. Donaghey, J. McGill, et al.
Development in children with achondroplasia: a prospective clinical cohort study.
Dev Med Child Neurol., 54 (2012), pp. 532-537
[51]
M. Stender, J.M. Pimenta, M. Cheung, M. Irving, S. Mukherjee.
Comprehensive literature review on the prevalence of comorbid conditions in patients with achondroplasia.
Bone., 162 (2022),
[52]
E. Okenfuss, B. Moghaddam, A.L. Avins.
Natural history of achondroplasia: a retrospective review of longitudinal clinical data.
Am J Med Genet A., 182A (2020), pp. 2540-2551
[53]
J.A. Armstrong, V. Pacey, L.J. Tofts.
Medical complications in children with achondroplasia.
Dev Med Child Neurol., 64 (2022), pp. 989-997
[54]
J. Llerena, P. Rosselli, A. Aragão, et al.
Lifetime impact study for achondroplasia (LISA): findings from an observational and multinational study focused on health-related quality of life in individuals with achondroplasia in Latin America.
Genet Med Open., 2 (2023),
[55]
K. Zasadzińska-Stempniak, H. Zajączkiewicz, A. Kukwa.
Prevalence of obstructive sleep apnea in the young adult population: a systematic review.
[56]
J.C. Lumeng, R.D. Chervin.
Epidemiology of pediatric obstructive sleep apnea.
Proc Am Thorac Soc., 5 (2008), pp. 242-252
[57]
GBD 2019 Hearing Loss Collaborators.
Hearing loss prevalence and years lived with disability, 1990-2019: findings from the Global Burden of Disease Study 2019.
Copyright © 2026. The Authors
Download PDF
Brazilian Journal of Otorhinolaryngology (English Edition)
Article options
Tools